Characterization of ¹²⁵I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors

Keyphrases

• Benzamide 100%
• 125I 100%
• Dopamine Receptor 100%
• D2-like 100%
• High Affinity 18%
• Radioligand 18%
• HEK293 Cells 18%
• Low Affinity 18%
• D3 Dopamine Receptor 18%
• D2 Dopamine Receptor 18%
• Caudate 18%
• Dopamine 9%
• Striatum 9%
• Selective Antagonist 9%
• Kd Values 9%
• Receptor Subtypes 9%
• Pharmacologic 9%
• Membrane Preparation 9%
• Dissociation Constant 9%
• Binding Studies 9%
• A1 Receptor 9%
• 2 Receptor 9%
• Unique Properties 9%
• D4 Dopamine Receptor 9%
• Azabicyclo 9%
• HEK Cells 9%
• Saturation Binding 9%
• Olfactory Tubercle 9%
• Structural Analogues 9%
• Rat Brain Slices 9%
• Adenylyl Cyclase Activity 9%
• Monophasic 9%
• Non-specific Binding 9%
• D1 Dopamine Receptor 9%
• Kinetic Experiments 9%
• Na+ Concentration 9%

Neuroscience

• Iodine-125 100%
• Benzamide 100%
• Dopamine Receptor 100%
• Dopamine Receptor D2 27%
• Radioligand 18%
• HEK 293 Cells 18%
• Receptor Subtype 18%
• D2-Like Receptor 18%
• Striatum 9%
• Adenylyl Cyclase 9%
• Brain Slice 9%
• Dopamine Receptor D1 9%
• Olfactory Tubercle 9%
• Receptor 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Benzamide 100%
• Iodine-125 100%
• Dopamine Receptor 100%
• Receptor 27%
• Dopamine Receptor D2 27%
• Radioligand 18%
• Receptor Subtype 18%
• Adenylate Cyclase 9%
• Electrolyte Solution 9%
• Sodium Ion 9%
• Benzamide Derivative 9%
• Dopamine 1 Receptor 9%